Adastra Holdings Ltd.
Adastra Holdings Ltd. extracts and processes cannabis for recreational and medical markets in Canada. The company offers vape pens, wax, resin, infused pre-rolls, diamonds, and shatters under the Endgame brand name. It also provides consulting, white label manufacturing, and tolling services; and licenses its intellectual property for the sale of consumer-packaged goods. The company was formerly … Read more
Adastra Holdings Ltd. (XTXXD) - Net Assets
Latest net assets as of September 2024: $13.54 Million USD
Based on the latest financial reports, Adastra Holdings Ltd. (XTXXD) has net assets worth $13.54 Million USD as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($31.08 Million) and total liabilities ($17.54 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $13.54 Million |
| % of Total Assets | 43.56% |
| Annual Growth Rate | 13.35% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 66.37 |
Adastra Holdings Ltd. - Net Assets Trend (2020–2023)
This chart illustrates how Adastra Holdings Ltd.'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Adastra Holdings Ltd. (2020–2023)
The table below shows the annual net assets of Adastra Holdings Ltd. from 2020 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $14.69 Million | -19.44% |
| 2022-12-31 | $18.23 Million | -18.52% |
| 2021-12-31 | $22.37 Million | +121.82% |
| 2020-12-31 | $10.09 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Adastra Holdings Ltd.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1057622000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $36.44 Million | 248.14% |
| Total Equity | $14.69 Million | 100.00% |
Adastra Holdings Ltd. Competitors by Market Cap
The table below lists competitors of Adastra Holdings Ltd. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
LJQQ3F
SA:LJQQ3F
|
$2.94K |
|
Petrovienam Securities Inc
VN:PSI
|
$2.94K |
|
Eenergy Group PLC
LSE:EAAS
|
$2.94K |
|
The Searle Company Ltd
KAR:SEARL
|
$2.95K |
|
Techcom Vietnam REIT Fund
VN:FUCVREIT
|
$2.94K |
|
4SC - Dusseldorf Stock Exchang
DU:VSC
|
$2.93K |
|
G3 Exploration Ltd
STU:G3J
|
$2.93K |
|
Clone Algo Technologies Inc
PINK:CATI
|
$2.93K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Adastra Holdings Ltd.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 18,229,790 to 14,685,148, a change of -3,544,642 (-19.4%).
- Net loss of 3,544,642 reduced equity.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-3.54 Million | -24.14% |
| Total Change | $- | -19.44% |
Book Value vs Market Value Analysis
This analysis compares Adastra Holdings Ltd.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.21x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 1.36x to 1.21x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $0.23 | $0.32 | x |
| 2021-12-31 | $0.34 | $0.32 | x |
| 2022-12-31 | $0.33 | $0.32 | x |
| 2023-12-31 | $0.26 | $0.32 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Adastra Holdings Ltd. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -24.14%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -15.95%
- • Asset Turnover: 0.69x
- • Equity Multiplier: 2.20x
- Recent ROE (-24.14%) is above the historical average (-33.86%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | -75.51% | -304.71% | 0.18x | 1.36x | $-8.62 Million |
| 2021 | -12.29% | -48.86% | 0.20x | 1.29x | $-4.99 Million |
| 2022 | -23.49% | -32.20% | 0.42x | 1.74x | $-6.10 Million |
| 2023 | -24.14% | -15.95% | 0.69x | 2.20x | $-5.01 Million |
Industry Comparison
This section compares Adastra Holdings Ltd.'s net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Adastra Holdings Ltd. (XTXXD) | $13.54 Million | -75.51% | 1.30x | $2.94K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |